Antisense technology and prospects for therapy of viral infections and cancer
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 3 (1), 31-38
- https://doi.org/10.1016/s1357-4310(96)10053-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Elucidation of gene function using C-5 propyne antisense oligonucleotidesNature Biotechnology, 1996
- Phosphorothioate antisense oligodeoxynucleotides: questions of specificityTrends in Biotechnology, 1996
- Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modificationsNucleic Acids Research, 1996
- Life, death, and the pursuit of apoptosis.Genes & Development, 1996
- New Drugs: Antisense Oligodeoxynucleotides as Clinical Therapeutic AgentsCancer Investigation, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Current concepts in antisense drug designJournal of Medicinal Chemistry, 1993
- Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne PyrimidinesScience, 1993